MYC and lung cancer: Based on all data obtained from this study, we proposed a hypothesis that the anticancer activity of SGH may be the result of c-Myc destabilization through the downregulation of USP28, resulting in the downregulation of cell cycle-, nucleotide synthesis-, and glycolysis-related regulators to arrest cell cycle and inhibit glycolysis in lung cancer cells.